Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-181025
Filing Date
2020-06-26
Accepted
2020-06-26 16:35:36
Documents
8
Effectiveness Date
2020-06-26

Document Format Files

Seq Description Document Type Size
1 S-8 d944243ds8.htm S-8 62284
2 EX-4.4 d944243dex44.htm EX-4.4 107521
3 EX-4.5 d944243dex45.htm EX-4.5 123929
4 EX-5.1 d944243dex51.htm EX-5.1 9669
5 EX-23.1 d944243dex231.htm EX-23.1 1521
6 EX-23.2 d944243dex232.htm EX-23.2 1671
7 GRAPHIC g9442431.jpg GRAPHIC 10299
8 GRAPHIC g944243g0626020038025.jpg GRAPHIC 1665
  Complete submission text file 0001193125-20-181025.txt   324365
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239491 | Film No.: 20994543
SIC: 2835 In Vitro & In Vivo Diagnostic Substances